North America Human Liver Models Market
Published On: Nov 2021
Published On: Nov 2021
According to a new market research study on “North America Human Liver Models Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Type, Application, and End User,” is expected to reach US$ 2,08,998.55 thousand by 2028 from US$ 98,522.08 thousand in 2021. The market is estimated to grow at a CAGR of 11.3% from 2021 to 2028. The report provides trends prevailing in the North America human liver models market along with the drivers and restraints pertaining to the market growth. Rising prevalence of liver diseases and increasing focus on developing alternatives for animal testing models are the major factor driving the growth of the North America human liver models market. However, expensive liver models hinders the growth of North America human liver models market.
According to the Centers for Disease Control and Prevention (CDC), patients with chronic liver disease or who are immunocompromised are at a higher risk of severe sickness from COVID-19. The rapid rise in reported COVID-19 cases in the US necessitated widespread changes in healthcare practices across the country. Although organ transplantation is frequently a medical emergency, the growing demand for and use of hospital resources has negatively affected transplant centers' ability to perform these life-saving procedures. COVID-19-related issues have hampered liver transplantation in the region, posing a threat to the human liver models market over the anticipated period.
The North America human liver models market has been segmented based on type, application, end user, and country. Based on type, the market is segmented into liver organoids, liver-on-a-chip, 2D models, 3D bioprinting, and others. The liver organoids segment dominated the market in 2020 and liver-on-a-chip segment is expected to be fastest growing during forecast period. Based on application, the market is segmented based on drug discovery, educational, and others. The drug discovery segment dominated the market in 2020 and same segment is expected to be fastest growing during forecast period. Based on end user, the market is segmented into pharmaceutical and biotechnology companies, research institutes, and others. The pharmaceutical and biotechnology companies segment dominated the market in 2020 and same segment is expected to be fastest growing during forecast period. Based on country, the market has been segmented into the US, Canada, and Mexico.
BioIVT; CELLINK; Emulate, Inc.; InSphero; Kerafast; MIMETAS BV; ORGANOVO HOLDINGS INC.; and THERMO FISHER SCIENTIFIC INC. are among the leading companies in the North America human liver models market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2021, BioIVT launched its HEPATOMUNE kit, a long-term, stable, in vitro model for evaluating immune-related and inflammation-mediated liver injury.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
